Ligase Market - A Global and Regional Analysis

1
Ligase Market - A Global and Regional Analysis
Table of Content
Focus on Product, Source, Application, End User,
and Country Analysis and Forecast
2022-2032 June 2022
T E K R A M E S A G I L L A B
O L 1 G All rights reserved at BIS Research Inc.
2
BIS Research is a leading market intelligence and
technology research company. BIS Research
publishes in- depth market intelligence reports
focusing on market estimations, technology
analysis, emerging high-growth applications,
deeply segmented granular country-level market
data, and other important market parameters
useful in the strategic decision making for
senior management. BIS Research provides
multi-client reports, company profiles,
databases, and custom research services.
Copyright 2022 BIS Research Inc. All Rights
Reserved. This document contains highly
confidential information and is the sole property
of BIS Research. Disclosing, copying,
circulating, quoting, or otherwise reproducing
any or all contents of this document is strictly
prohibited. Access to this information is
provided exclusively for the benefit of the
people or organization concerned. It may not be
accessed by or offered, whether for sale or
otherwise, to any third party.
GLOBAL LIGASE MARKET
2
3
Table of Content Executive Summary................
..................................................
........18 1. Market .............................
..................................................
........24 1.1 Product Definition.................
..................................................
.........................25 1.1.1 Inclusion and
Exclusion ........................................
.....................................25 1.2 Ligase
Market Workflow..................................
................................................25
1.3 Market Scope ................................
..................................................
.................26 1.3.1 Scope of the Study
..................................................
....................................26 1.3.2
Key Questions Answered in the Report
..................................................
..26 2. Research Methodology .....................
.........................................28 2.1 Gl
obal Ligase Market Research Methodology
.............................................29
2.2 Data Sources..................................
..................................................
................29 2.2.1 Primary Data Sources
..................................................
...............................29 2.2.2
Secondary Data Sources ...........................
.................................................3
0 2.3 Market Estimation Model.....................
..................................................
..........31 2.4 Criteria for Company
Profiling.........................................
...............................33 3. Global
Ligase Market Market Overview ...................
..................34 3.1 Overview.................
..................................................
........................................35 3.2 Mar
ket Footprint and Growth Potential, Million,
2021-2032 .......................35 3.3 COVID-19
Impact on Global Ligase Market ...................
................................36 3.3.1 Impact
on Market Growth Due to COVID-19
..............................................36 4
. Industry Analysis ..............................
.........................................37 4.1 Re
gulatory Framework Overview ......................
.............................................38 4.
1.1 Regulatory Guidelines of Ligase Enzymes
...............................................38
4.1.1.1 Regulatory Framework in the
U.S...............................................
....................... 38 4.1.1.2 Regulatory
Framework in the European Union...................
............................... 39 4.2 Patent
Analysis .........................................
..................................................
.....39 4.2.1 By Region.........................
..................................................
..........................39 4.2.2 By Year
..................................................
..................................................
.....40 3
GLOBAL LIGASE MARKET
4

• 5. Market Dynamics ...............................
  ........................................41
• 5.1 Overview......................................
  ..................................................
  ...................42
• 5.2 Impact Analysis ..............................
  ..................................................
  ...............42
• 5.3 Market Drivers................................
  ..................................................
  ................43
• Growing Need for Ligases in Disease Treatment
  .....................................43
• Rising Incidence of Diseases such as Cancer and
  Genetic Disorders................................
  ..................................................
  ....................44
• Rising Focus of Researchers on Non-Toxic
  Biocatalyst .........................44
  5.4 Market Restraints.............................
  ..................................................
  ..............45
• 5.4.1 High Reception Costs Involving Small and
  Medium Enterprises............45
• 5.4.2 Variation in the Ability of Ligase to
  Repair ...........................................
  ....45 5.5 Market Opportunities..................
  ..................................................
  ...................45
• 5.5.1 Utilization of PCR-Based Frameworks
  ..................................................
  ....45
• 5.5.2 Recuperation of Lost or Rearranged Genetic
  Information ......................46
  6. Competitive Landscape .........................
  ....................................47
  6.1 Competitive Landscape .......................
  ..................................................
  .........48 6.1.1 Mergers and Acquisitions.......
  ..................................................
  ..................48 6.1.2 Synergistic
  Activities .......................................
  ...........................................49
  6.1.3 Product Launches ...........................
  ..................................................
  ..........50 6.1.4 Fundings and Expansions
  ..................................................
  ........................50
• 6.2 Supply Chain Analysis ........................
  ..................................................
  ..........50
• 6.3 Pricing Analysis (by Product).................
  ..................................................
  ......52
• 6.3.1 Market Share Analysis (2021)
  ..................................................
  ...................52
• 6.3.2 Growth-Share Analysis (2021)..............
  ..................................................
  ....53
• 6.3.2.1 Growth-Share Analysis by Company
  ..................................................
  ............... 53
• 6.3.2.2 Growth-Share Analysis by Application
  Type..............................................
  ........ 55
• 6.3.2.3 Growth-Share Analysis by End User
  ..................................................
  ............... 56
• 7. Global Ligase Market (by Product Type), Value
  (Million) Volume (Units), 2021-2032
  ..................................................
  .......58

GLOBAL LIGASE MARKET
4
5

• 7.1.1 Quick Ligase .............................
  ..................................................
  .................59
• 7.1.2 T4 DNA Ligase ............................
  ..................................................
  ...............61
• 7.1.3 E. coli DNA Ligase........................
  ..................................................
  .............63
• 7.1.4 Tth DNA Ligase............................
  ..................................................
  ..............65
• 7.1.5 T4 RNA Ligase ............................
  ..................................................
  ...............67
• 7.1.6 Pfu DNA Ligase............................
  ..................................................
  ..............69
• 7.1.7 Others.....................................
  ..................................................
  ....................70
• Global Ligase Market (by Source Type), Value
  (Million), 2021- 2032 ..........................
  ..................................................
  ..............73
• 8.1 Source Outlook ...............................
  ..................................................
  ...............74
• 8.1.1 Archaebacterium ..........................
  ..................................................
  .............74
• 8.1.2 Escherichia coli .........................
  ..................................................
  ................75
• 8.1.3 Thermus thermophilus......................
  ..................................................
  ........76
• 8.1.4 Pyrococcus furiosus ......................
  ..................................................
  ...........77
• 8.1.5 Others.....................................
  ..................................................
  ....................78
• Global Ligase Market (by Application), Value
  (Million), 2021- 2032 ..........................
  ..................................................
  ..............79
• 9.1 Application Outlook...........................
  ..................................................
  ............80
• 9.1.1 Ligase Chain Reaction (LCR)
  ..................................................
  ...................80
• 9.1.2 Ligase Detection Reaction (LDR)
  ..................................................
  .............81
• 9.1.3 Next-Generation Sequencing (NGS)
  ..................................................
  ........82

GLOBAL LIGASE MARKET
5
6
10.1 End User Outlook ............................
..................................................
..............92 10.1.1 Research Laboratories and
Institutions .....................................
...............92 10.1.2 Pharmaceutical and
Biopharmaceutical Companies ......................
.........93 10.1.3 Diagnostic Laboratories
..................................................
...........................95 10.1.4
Others............................................
..................................................
.............96 11. Global Ligase Market (by
Region), Value (Million) Volume (Units),
2021-2032 ........................................
.............................98 11.1 Regional
Outlook ..........................................
..................................................
.99 11.2 North America ...........................
..................................................
...................100 11.2.1 Key Dynamics
..................................................
..........................................101 11.2
.2 U.S ...........................................
..................................................
.................101 11.2.3 Canada
..................................................
..................................................
...103 11.3 Europe ...............................
..................................................
...........................104 11.3.1 Key
Dynamics .........................................
..................................................
.106 11.3.2 France................................
..................................................
.......................106 11.3.3
Germany...........................................
..................................................
........108 11.3.4 U.K. ..........................
..................................................
.................................109 11.3.5 Italy
..................................................
..................................................
.........111 11.3.6 Spain.........................
..................................................
................................112 11.3.7
Rest-of-Europe....................................
..................................................
.....114 11.4 Asia-Pacific (APAC).................
..................................................
....................115 11.4.1 Key Dynamics
..................................................
..........................................116 11.4
.2 China .........................................
..................................................
...............117 11.4.3 Japan
..................................................
..................................................
......118 11.4.4 India ...........................
..................................................
...............................120 11.4.5
Australia ........................................
..................................................
...........121 11.4.6 South Korea
..................................................
.............................................123 1
1.4.7 Rest-of-Asia-Pacific........................
..................................................
.........124 11.5 Latin America (LATAM)
..................................................
...............................126 11.5.1 Key
Dynamics .........................................
..................................................
.127 6
GLOBAL LIGASE MARKET
7
11.5.2 Brazil.....................................
..................................................
....................127 11.5.3 Mexico
..................................................
..................................................
....129 11.5.4 Rest-of-the-LATAM..................
..................................................
................130 11.6 Rest-of-the-World
..................................................
........................................132 12.
Company Profiles..................................
...................................
134 12.1 Agilent Technologies, Inc.
..................................................
..........................135 12.1.1 Company
Overview .........................................
..........................................135 12.1
.2 Role of Agilent Technologies, Inc. in the
Global Ligase Market............135 12.1.3 Key
Competitors of the Company........................
....................................135 12.1.4
Key Customers of the Company .....................
.........................................135 12.1.
5 Financials .....................................
..................................................
............136 12.1.6 Analyst Perspective
..................................................
................................139 12.2 ArcticZym
es Technologies ASA...............................
....................................140 12.2.1
Company Overview .................................
..................................................
140 12.2.2 Role of ArcticZymes Technologies ASA
in the Global Ligase Market ......................
..................................................
............................................140 12
.2.3 Key Competitors of the Company...............
.............................................140 1
2.2.4 Key Customers of the Company
..................................................
............140 12.2.5 Corporate Strategies
..................................................
...............................141 12.2.6
Financials .......................................
..................................................
..........142 12.2.7 Analyst Perspective
..................................................
................................144 12.3 BD
..................................................
..................................................
...............145 12.3.1 Company Overview
..................................................
.................................145 12.3.2 Role
of BD in the Global Ligase Market.................
..................................145 12.3.3 Key
Competitors of the Company........................
....................................145 12.3.4
Key Customers of the Company .....................
.........................................146 12.3.
5 Financials .....................................
..................................................
............146 12.3.6 Analyst Perspective
..................................................
................................148 12.4 Bio-Rad
Laboratories, Inc. ...............................
.............................................149 1
2.4.1 Company Overview ...........................
..................................................
......149 7
GLOBAL LIGASE MARKET
8
12.4.2 Role of Bio-Rad Laboratories, Inc. in the
Global Ligase Market ...........149 12.4.3 Key
Competitors of the Company........................
....................................149 12.4.4
Key Customers of the Company .....................
.........................................149 12.4.
5 Financials .....................................
..................................................
............150 12.4.6 Analyst Perspective
..................................................
................................153 12.5 Codexis,
Inc...............................................
..................................................
...154 12.5.1 Company Overview ...................
..................................................
..............154 12.5.2 Role of Codexis, Inc. in
the Global Ligase Market..........................
........154 12.5.3 Key Competitors of the
Company...........................................
.................154 12.5.4 Key Customers of the
Company ..........................................
....................154 12.5.5 Corporate
Strategies .......................................
..........................................155 12.5
.6 Financials ....................................
..................................................
.............156 12.5.7 Analyst Perspective
..................................................
................................158 12.6 F.
Hoffmann-La Roche Ltd. ...........................
................................................15
9 12.6.1 Company Overview ........................
..................................................
.........159 12.6.2 Role of F. Hoffmann-La Roche
Ltd. in the Global Ligase Market ..........159
12.6.3 Key Competitors of the Company.............
...............................................159
12.6.4 Key Customers of the Company
..................................................
............159 12.6.5 Corporate Strategies
..................................................
...............................160 12.6.6
Financials .......................................
..................................................
..........160 12.6.7 Analyst Perspective
..................................................
................................163
12.7 Inspiralis Limited, Inc. ....................
..................................................
.............164 12.7.1 Company Overview
..................................................
.................................164 12.7.2 Role
of Inspiralis Limited, Inc. in the Global Ligase
Market ..................164 12.7.3 Key
Competitors of the Company........................
....................................164 12.7.4
Key Customers of the Company .....................
.........................................164 12.7.
5 Analyst Perspective ............................
..................................................
....165 12.8 Merck KGaA ..........................
..................................................
.......................166 12.8.1 Company
Overview .........................................
..........................................166 12.8
.2 Role of Merck KGaA in the Global Ligase
Market...................................166 8
GLOBAL LIGASE MARKET
9
12.8.3 Key Competitors of the Company.............
...............................................166
12.8.4 Key Customers of the Company
..................................................
............166 12.8.5 Corporate Strategies
..................................................
...............................167 12.8.6
Financials .......................................
..................................................
..........167 12.8.7 Analyst Perspective
..................................................
................................170 12.9 New
England Biolabs (UK) Ltd. ........................
............................................171 12
.9.1 Company Overview ............................
..................................................
.....171 12.9.2 Role of New England Biolabs (UK)
Ltd. In the Global Ligase Market ...171 12.9.3
Key Competitors of the Company....................
........................................171 12.9.4
Analyst Perspective .............................
..................................................
...172 12.10 Promega Corporation
..................................................
..................................173 12.10.1 Comp
any Overview......................................
.......................................173 12.10.2
Role of Promega Corporation in the Global
Ligase Market.............173 12.10.3 Key
Competitors of the Company .......................
..............................173
12.10.4 Analyst Perspective ......................
..................................................
....174 12.11 QIAGEN N.V.........................
..................................................
.........................175 12.11.1 Company
Overview..........................................
...................................175 12.11.2 Rol
e of QIAGEN N.V. in the Global Ligase Market
...........................175 12.11.3 Key
Competitors of the Company .......................
..............................175 12.11.4 Key
Customers of the Company..........................
..............................175 12.11.5 Corporat
e strategies .....................................
......................................176 12.11.6
Financials .......................................
..................................................
...177 12.11.7 Analyst Perspective
..................................................
..........................179 12.12 SBS Genetech
..................................................
..............................................180
12.12.1 Company Overview..........................
..................................................
.180 12.12.2 Role of SBS Genetech in the Global
Ligase Market.........................180
12.12.3 Key Competitors of the Company
..................................................
...180 12.12.4 Key Customers of the
Company...........................................
.............180 12.12.5 Analyst Perspective
..................................................
..........................181 12.13 Takara Bio
Inc. .............................................
..................................................
182
GLOBAL LIGASE MARKET
10
12.13.1 Company Overview..........................
..................................................
.182 12.13.2 Role of Takara Bio Inc. in the
Global Ligase Market ........................182
12.13.3 Key Competitors of the Company
..................................................
...182 12.13.4 Key Customers of the
Company...........................................
.............182 12.13.5 Financials
..................................................
..........................................183 12.1
3.6 Analyst Perspective ..........................
..................................................
186 12.14 Thermo Fisher Scientific,
Inc...............................................
.........................187 12.14.1 Company
Overview..........................................
...................................187 12.14.2 Rol
e of Thermo Fisher Scientific, Inc. in the Global
Ligase Market....................................
..................................................
...................187 12.14.3 Key Competitors of
the Company ......................................
...............187 12.14.4 Key Customers of the
Company...........................................
.............187 12.14.5 Financials
..................................................
..........................................188 12.1
4.6 Analyst Perspective ..........................
..................................................
191 12.15 Emerging Companies ....................
..................................................
..............192 12.15.1 Tinzyme Ltd.
..................................................
......................................192 12.15.2
Hotspot Therapeutics .............................
............................................192 12
.15.3 Nurix Therapeutics..........................
..................................................
..193 12.15.4 Vividion Therapeutics...............
..................................................
........193
GLOBAL LIGASE MARKET
11
List of Figures
Figure 1 Growth Strategy by Companies
Figure 2 Top Eight Infectious Diseases by Disability-Adjusted Life Years (DALY)
Figure 3 Global Ligase Market (by Product), Million, 2021 and 2032
Figure 4 Global Ligase Market (by Source), Million, 2021 and 2032
Figure 5 Global Ligase Market (by Application), 2021 and 2032
Figure 6 Global Ligase Market (by End User), Million, 2021 and 2032
Figure 7 Global Ligase Market Snapshot
Figure 8 Ligase Market Workflow
Figure 9 Global Ligase Market Segmentation
Figure 10 Global Ligase Market Research Methodology
Figure 11 Primary Research Methodology
Figure 12 Bottom-Up Approach (Segment-Wise Analysis)
Figure 13 Top-Down Approach (Segment-Wise Analysis)
Figure 14 Global Ligase Market, Million, 2021-2032
Figure 15 Region-Wise Analysis (January 2019-June 2022) of Patents Related to the Global Ligase market
Figure 16 Year-Wise Analysis (January 2019-June 2022) of Patents Related to the Global Ligase market
Figure 17 Market Dynamics
Figure 18 Likert Scale
Figure 19 Impact Analysis
Figure 20 Alzheimers Disease Prevalence in the Year 2019 in Men Population
Figure 21 List of Ligase Type with Respect to Disease Type
Figure 22 Share of Key Developments and Strategies, January 2019-January 2022
Figure 23 Share of Acquisitions (by Company), January 2019-January 2022
Figure 24 Synergistic Activities Share (by Company), January 2019-January 2022
Figure 25 Product Launches (by Company), January 2019-January 2022
Figure 26 Share of Funding Activities (by Company), January 2019-January 2022
Figure 27 Supply Chain Analysis of the Global Ligase Market
Figure 28 Market Share Analysis for Global Ligase Market, Million, 2021
Figure 29 Growth-Share Analysis of the Global Ligase Market (by Company), 2021
Figure 30 Growth-Share Matrix for Global Ligase Market (by Application Type), 2021
GLOBAL LIGASE MARKET
12
Figure 31 Growth-Share Matrix for Global Ligase Market (by End User), 2021
Figure 32 Global Ligase Market (Quick Ligase), Million, 2021-2032
Figure 33 Global Ligase Market (Quick Ligase), Million Units, 2021-2032
Figure 34 Global Ligase Market (T4 DNA Ligase), Million, 2021-2032
Figure 35 Global Ligase Market (T4 DNA Ligase), Million Units, 2021-2032
Figure 36 Global Ligase Market (E. coli Ligase), Million, 2021-2032
Figure 37 Global Ligase Market (E. coli Ligase), Million Units, 2021-2032
Figure 38 Global Ligase Market (Tth DNA Ligase), Million, 2021-2032
Figure 39 Global Ligase Market (Tth DNA Ligase), Million Units, 2021-2032
Figure 40 Global Ligase Market (T4 RNA Ligase), Million, 2021-2032
Figure 41 Global Ligase Market (T4 RNA Ligase), Million Units, 2021-2032
Figure 42 Global Ligase Market (Pfu DNA Ligase), Million, 2021-2032
Figure 43 Global Ligase Market (Pfu DNA Ligase), Million Units, 2021-2032
Figure 44 Global Ligase Market (Others), Million, 2021-2032
Figure 45 Global Ligase Market (Others), Million Units, 2021-2032
Figure 46 Global Ligase Market (Archaebacterium), Million, 2021-2032
Figure 47 Global Ligase Market (E. coli), Million, 2021-2032
Figure 48 Global Ligase Market (Thermus Thermophillus), Million, 2021-2032
Figure 49 Global Ligase Market (Pyrococcus furiosus), Million, 2021-2032
Figure 50 Global Ligase Market (Others), Million, 2021-2032
Figure 51 Global Ligase Market (Ligase Chain Reaction), Million, 2021-2032
Figure 52 Global Ligase Market (Ligase Detection Reaction), Million, 2021-2032
Figure 53 Global Ligase Market (Next-Generation Sequencing), Million, 2021-2032
Figure 54 Global Ligase Market (Repeat Expansion Detection), Million, 2021-2032
Figure 55 Global Ligase Market (Rolling Circle Amplification), Million, 2021-2032
Figure 56 Global Ligase Market (Proximity Ligation Assay), Million, 2021-2032
Figure 57 Global Ligase Market (Molecular Cloning), Million, 2021-2032
Figure 58 Global Ligase Market (Ligation Mediated PCR), Million, 2021-2032
Figure 59 Global Ligase Market (Mutation Detection), Million, 2021-2032
Figure 60 Global Ligase Market (Others), Million, 2021-2032
Figure 61 Global Ligase Market (Research Laboratories and Institutions), Million, 2021-2032
Figure 62 Global Ligase Market (Research Laboratories and Institutions), Million Units, 2021-2032
GLOBAL LIGASE MARKET
13
Figure 63 Global Ligase Market (Pharmaceutical and Biopharmaceutical Companies), Million, 2021- 2032
Figure 64 Global Ligase Market (Pharmaceutical and Biopharmaceutical Companies), Million Units, 2021-2032
Figure 65 Global Ligase Market (Diagnostic Laboratories), Million, 2021-2032
Figure 66 Global Ligase Market (Diagnostic Laboratories), Million Units, 2021-2032
Figure 67 Global Ligase Market (Others), Million, 2021-2032
Figure 68 Global Ligase Market (Others), Million Units, 2021-2032
Figure 69 Global Ligase Market Snapshot (by Region)
Figure 70 Growth Potential Analysis (by Country)
Figure 71 North America Market Dynamics
Figure 72 U.S. Ligase Market, Million, 2021-2032
Figure 73 Canada Ligase Market, Million, 2021-2032
Figure 74 Growth Potential Analysis (by Country)
Figure 75 Europe Market Dynamics
Figure 76 France Ligase Market, Million, 2021-2032
Figure 77 Germany Ligase Market, Million, 2021-2032
Figure 78 U.K. Ligase Market, Million, 2021-2032
Figure 79 Italy Ligase Market, Million, 2021-2032
Figure 80 Spain Ligase Market, Million, 2021-2032
Figure 81 Rest-of-Europe Ligase Market, Million, 2021-2032
Figure 82 Growth Potential Analysis (by Country)
Figure 83 APAC Market Dynamics
Figure 84 China Ligase Market, Million, 2021-2032
Figure 85 Japan Ligase Market, Million, 2021-2032
Figure 86 India Ligase Market, Million, 2021-2032
Figure 87 Ligase Market, Million, 2021-2032
Figure 88 South Korea Ligase Market, Million, 2021-2032
Figure 89 Rest-of-Asia-Pacific Ligase Market, Million, 2021-2032
Figure 90 Growth Potential Analysis (by Country)
Figure 91 LATAM Market Dynamics
Figure 92 Brazil Ligase Market, Million, 2021-2032
Figure 93 Mexico Ligase Market, Million, 2021-2032
GLOBAL LIGASE MARKET
13
14
Figure 94 Rest-of-the-LATAM Ligase Market, Million, 2021-2032
Figure 95 Rest-of-the-World Ligase Market, Million, 2021-2032
Figure 96 Agilent Technologies, Inc. Product Portfolio
Figure 97 Agilent Technologies, Inc. Overall Financial 2019-2021
Figure 98 Agilent Technologies, Inc. Revenue (by Segment), Million, 2019-2021
Figure 99 Agilent Technologies, Inc. Revenue (by Region), Million, 2019-2021
Figure 100 Agilent Technologies, Inc RD Expenditure, Million, 2019-2021
Figure 101 ArcticZymes Technologies ASA Product Portfolio
Figure 102 ArcticZymes Technologies ASA Overall Financials, 2019-2021
Figure 103 ArcticZymes Technologies ASA Revenue (by Segment), Million, 2019-2021
Figure 104 ArcticZymes Technologies ASA RD Expenditure, Million, 2019-2021
Figure 105 BD. Product Portfolio
Figure 106 BD. Overall Financials, 2019-2021
Figure 107 BD. Revenue (by Segment), Million, 2019-2021
Figure 108 BD. Revenue (by Region), Million, 2019-2021
Figure 109 BD. RD Expenditure, Million, 2019-2021
Figure 110 Bio-Rad Laboratories, Inc. Product Portfolio
Figure 111 Bio-Rad Laboratories, Inc. Overall Financials, 2019-2021
Figure 112 Bio-Rad Laboratories, Inc. Revenue (by Segment), Million, 2019-2021
Figure 113 Bio-Rad Laboratories, Inc. Revenue (by Region), Million, 2019-2021
Figure 114 Bio-Rad Laboratories, Inc. RD Expenditure, Million, 2019-2021
Figure 115 Codexis, Inc. Product Portfolio
Figure 116 Codexis, Inc. Overall Financials, 2019-2021
Figure 117 Codexis, Inc. Revenue (by Segment), Million, 2019-2021
Figure 118 Codexis, Inc. Revenue (by Region), Million, 2019-2021
Figure 119 Codexis, Inc. RD Expenditure, Million, 2019-2021
Figure 120 F. Hoffmann-La Roche Ltd. Product Portfolio
Figure 121 F. Hoffmann-La Roche Ltd. Overall Financials, 2019-2021
Figure 122 F. Hoffmann-La Roche Ltd. Revenue (by Segment), Million, 2019-2021
Figure 123 F. Hoffmann-La Roche Ltd. Revenue (by Region), Million, 2019-2021
Figure 124 F. Hoffmann-La Roche Ltd. RD Expenditure, Million, 2019-2021
Figure 125 Inspiralis Limited, Inc. Product Portfolio
Figure 126 Merck KGaA Product Portfolio
GLOBAL LIGASE MARKET
15
Figure 127 Merck KGaA Overall Financials, Million, 2019-2021
Figure 128 Merck KGaA Revenue (by Segment), Million, 2019-2021
Figure 129 Merck KGaA Revenue (by Region), Million, 2019-2021
Figure 130 Merck KGaA RD Expenditure, Million, 2019-2021
Figure 131 New England Biolabs (UK) Ltd. Product Portfolio
Figure 132 Promega Corporation Product Portfolio
Figure 133 QIAGEN N.V. Product Portfolio
Figure 134 QIAGEN N.V. Overall Financials, 2019-2021
Figure 135 QIAGEN N.V. Revenue (by Segment), Million, 2019-2021
Figure 136 QIAGEN N.V. Revenue (by Region), Million, 2019-2021
Figure 137 QIAGEN N.V. RD Expenditure, 2019-2021
Figure 138 SBS Genetech Product Portfolio
Figure 139 Takara Bio Inc. Product Portfolio
Figure 140 Takara Bio Inc. Overall Financials, 2019-2021
Figure 141 Takara Bio Inc. Revenue (by Segment), Million, 2019-2021
Figure 142 Takara Bio Inc. Revenue (by Region), Million, 2019-2021
Figure 143 Takara Bio Inc. RD Expenditure, Million, 2019-2021
Figure 144 Thermo Fisher Scientific, Inc. Product Portfolio
Figure 145 Thermo Fisher Scientific, Inc. Overall Financials, 2019-2021
Figure 146 Thermo Fisher Scientific, Inc. Revenue (by Segment), Million, 2019-2021
Figure 147 Thermo Fisher Scientific, Inc. Revenue (by Region), Million, 2019-2021
Figure 148 Thermo Fisher Scientific, Inc. RD Expenditure, Million, 2019-2021
GLOBAL LIGASE MARKET
16
List of Tables
Table 1 COVID-19 Impact on Global Ligase Market
Table 2 Companies Providing Quick Ligase Kits
Table 3 Companies Providing T4 DNA Ligase Kits
Table 4 Companies Providing E.coli DNA Ligase
Table 5 Companies Providing Tth Ligase
Table 6 Companies Providing T4RNA Ligase
Table 7 Companies Providing Pfu DNA Ligase
Table 8 Companies Providing Other DNA Ligase
Table 9 Companies Using E.coli Source for Products
Table 10 Companies Providing Thermus thermophilus Source for Products
Table 11 U.S. Ligase Market (by Application), Million, 2022, 2026, 2032
Table 12 Canada Ligase Market, by Application, Million, 2022, 2026, 2032
Table 13 France Ligase Market (by Application), Million, 2022, 2026, 2032
Table 14 Germany Ligase Market (by Application), Million, 2022, 2026, 2032
Table 15 U.K. Ligase Market (by Application), Million, 2022, 2026, 2032
Table 16 Italy Ligase Market (by Application), Million, 2022, 2026, 2032
Table 17 Spain Ligase Market, by Application, Million, 2022, 2026, 2032
Table 18 Rest-of-Europe Ligase Market (by Application), Million, 2022, 2026, 2032
Table 19 China Ligase Market, by Application, Million, 2022, 2026, 2032
Table 20 Japan Ligase Market, by Application, Million, 2022, 2026, 2032
Table 21 India Ligase Market, by Application, Million, 2022, 2026, 2032
Table 22 Australia Ligase Market, by Application, Million, 2022, 2026, 2032
Table 23 South Korea Ligase Market, by Application, Million, 2022, 2026, 2032
Table 24 Rest-of-Asia-Pacific Ligase Market (by Application), Million, 2022, 2026, 2032
Table 25 Brazil Ligase Market, by Application, Million, 2022, 2026, 2032
Table 26 Mexico Ligase Market (by Application), Million, 2022, 2026, 2032
Table 27 Rest-of-LATAM Ligase Market (by Application), Million, 2022, 2026, 2032
Table 28 Rest-of-the-World Ligase Market (by Application), Million, 2022, 2026, 2032
GLOBAL LIGASE MARKET
17
BIS Research Offerings
We are on a mission to harness the potential of
disruptive technologies to make businesses thrive
in todays digital age. We have the vision to be
a leading and preferred knowledge partner for
corporates and institutions worldwide and assist
them with market intelligence in the area of
emerging technologies, advisories, and other
innovative solutions.
Know More
Know More
Know More
GLOBAL LIGASE MARKET
Know More
18
Disclaimer
BIS Research Inc. provides valuable market
intelligence to an exclusive group of customers
in response to orders. The report is licensed
for the customer's internal use only and is
subject to restrictions set henceforth. This
document and its contents are confidential and
may not be further distributed, published or
reproduced, in whole or in part, by any medium
or in any form for any purpose, without the
express written consent of BIS Research Inc.
Customer will not disclose the contents of the
report, whether directly in any media or
indirectly through incorporation in a database,
marketing list, report or otherwise, or use or
permit the use of Information to generate any
statistical or other information that is or will
be provided to third parties or voluntarily
produce Information in legal proceedings.
Market reports are based on expectations,
estimates and projections as of the date such
information is available. Any recommendation
contained in this report may not be suitable for
all investors or businesses. The market
conclusions drawn are necessarily based upon a
number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of
the date of such statements, are inherently
subject to market fluctuations and business,
economic and competitive uncertainties and
contingencies
For more details regarding permission, please
contact us Email sales_at_bisresearch.com Tel 1
510 404 8135
GLOBAL LIGASE MARKET
19
BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite
313 Fremont, CA 94538 -1686 E-mail
hello_at_bisresearch.com Call Us 1-510-404-8135
Global Delivery Center Tower B First Floor,
Tapasya Corporate Heights, Greater Noida
Expressway, Sector 126, Noida, U.P., 201303,
India Tel [phone]
T E K R A M E S A G I L L A B O
L 19 G All rights reserved at BIS Research Inc.
www.bisresearch.com